SARTF
Price
$187.87
Change
-$2.13 (-1.12%)
Updated
Aug 22 closing price
Capitalization
14.38B
SDMHF
Price
$204.00
Change
+$4.99 (+2.51%)
Updated
Sep 3 closing price
Capitalization
19.72B
Interact to see
Advertisement

SARTF vs SDMHF

Header iconSARTF vs SDMHF Comparison
Open Charts SARTF vs SDMHFBanner chart's image
Sartorius AG
Price$187.87
Change-$2.13 (-1.12%)
Volume$1
Capitalization14.38B
Sartorius Stedim Biotech
Price$204.00
Change+$4.99 (+2.51%)
Volume$161
Capitalization19.72B
SARTF vs SDMHF Comparison Chart in %
Loading...
SARTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDMHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SARTF vs. SDMHF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SARTF is a Hold and SDMHF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (SARTF: $187.87 vs. SDMHF: $203.99)
Brand notoriety: SARTF and SDMHF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SARTF: 8% vs. SDMHF: 14%
Market capitalization -- SARTF: $14.38B vs. SDMHF: $19.72B
SARTF [@Pharmaceuticals: Other] is valued at $14.38B. SDMHF’s [@Pharmaceuticals: Other] market capitalization is $19.72B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SARTF’s FA Score shows that 0 FA rating(s) are green whileSDMHF’s FA Score has 0 green FA rating(s).

  • SARTF’s FA Score: 0 green, 5 red.
  • SDMHF’s FA Score: 0 green, 5 red.
According to our system of comparison, both SARTF and SDMHF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SARTF’s TA Score shows that 3 TA indicator(s) are bullish while SDMHF’s TA Score has 5 bullish TA indicator(s).

  • SARTF’s TA Score: 3 bullish, 4 bearish.
  • SDMHF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SDMHF is a better buy in the short-term than SARTF.

Price Growth

SARTF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while SDMHF (@Pharmaceuticals: Other) price change was -0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.57%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was +18.37%.

Industries' Descriptions

@Pharmaceuticals: Other (-1.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SDMHF($19.7B) has a higher market cap than SARTF($14.4B). SARTF has higher P/E ratio than SDMHF: SARTF (107.66) vs SDMHF (75.91). SDMHF YTD gains are higher at: 4.613 vs. SARTF (2.103). SARTF has higher annual earnings (EBITDA): 844M vs. SDMHF (740M). SARTF has more cash in the bank: 872M vs. SDMHF (745M). SDMHF has less debt than SARTF: SDMHF (2.97B) vs SARTF (4.66B). SARTF has higher revenues than SDMHF: SARTF (3.47B) vs SDMHF (2.9B).
SARTFSDMHFSARTF / SDMHF
Capitalization14.4B19.7B73%
EBITDA844M740M114%
Gain YTD2.1034.61346%
P/E Ratio107.6675.91142%
Revenue3.47B2.9B120%
Total Cash872M745M117%
Total Debt4.66B2.97B157%
FUNDAMENTALS RATINGS
SARTF vs SDMHF: Fundamental Ratings
SARTF
SDMHF
OUTLOOK RATING
1..100
8722
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8784
PRICE GROWTH RATING
1..100
6059
P/E GROWTH RATING
1..100
8878
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SDMHF's Valuation (75) in the null industry is in the same range as SARTF (77). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.

SDMHF's Profit vs Risk Rating (100) in the null industry is in the same range as SARTF (100). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.

SDMHF's SMR Rating (84) in the null industry is in the same range as SARTF (87). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.

SDMHF's Price Growth Rating (59) in the null industry is in the same range as SARTF (60). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.

SDMHF's P/E Growth Rating (78) in the null industry is in the same range as SARTF (88). This means that SDMHF’s stock grew similarly to SARTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SARTFSDMHF
RSI
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
63%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
59%
Momentum
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
59%
MACD
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
50%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
53%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
67%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
SARTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDMHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDTX64.931.50
+2.36%
Cidara Therapeutics
HQY97.702.16
+2.26%
HealthEquity
DYCQU11.10N/A
N/A
DT Cloud Acquisition Corp
RXST8.47-0.42
-4.72%
RxSight
QNTM14.29-1.41
-8.98%
Quantum Biopharma Ltd

SARTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SARTF has been loosely correlated with SDMHF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SARTF jumps, then SDMHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
SDMHF - SARTF
39%
Loosely correlated
N/A
SOAGY - SARTF
27%
Poorly correlated
-3.52%
EXAS - SARTF
21%
Poorly correlated
+4.34%
RSMDF - SARTF
16%
Poorly correlated
N/A
RYLPF - SARTF
9%
Poorly correlated
+1.36%
More

SDMHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SDMHF has been loosely correlated with SOAGY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SDMHF jumps, then SOAGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDMHF
1D Price
Change %
SDMHF100%
N/A
SOAGY - SDMHF
45%
Loosely correlated
-3.52%
SARTF - SDMHF
41%
Loosely correlated
N/A
RPID - SDMHF
30%
Poorly correlated
+2.52%
JNDOF - SDMHF
29%
Poorly correlated
N/A
SRTOY - SDMHF
22%
Poorly correlated
-3.33%
More